Prediction of pharmacokinetic behaviour by combining in vivo and in vitro data in physiologically based pharmacokinetic (PBPK) model: Parameter estimation and sensitivity analysis

被引：0

作者：

Das, Debasish ^{[1
]}

Dhurjati, Prasad ^{[2
]}

Wangikar, Pramod P. ^{[1
,3
]}

机构：

[1] Department of Chemical Engineering, Indian Institute of Technology, Bombay, Powai, Mumbai 400076, India

[2] Department of Chemical Engineering, University of Delaware, Newark, DE 19716, United States

[3] School of Biosciences and Bioengineering, Indian Institute of Technology, Bombay, Powai, Mumbai 400076, India

来源：

Journal of the Indian Institute of Science | 2008年 / 88卷 / 01期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：57 / 71

共 50 条

[41] Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data
Claassen, Karina
Thelen, Kirstin
Coboeken, Katrin
Gaub, Thomas
Lippert, Joerg
Allegaert, Karel
Willmann, Stefan
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (39) : 5688 - 5698
[42] PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF ELAGOLIX FOR PREDICTION OF DRUG-DRUG INTERACTIONS (DDIS)
Chiney, M. S.
Polepally, A. R.
Nader, A. M.
Dufek, M. B.
Klein, C. E.
Ng, J. W.
Shebley, M.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S59 - S59
[43] Prediction of dolutegravir pharmacokinetics and dose optimization in neonates via physiologically based pharmacokinetic (PBPK) modelling
Bunglawala, Fazila
Rajoli, Rajith K. R.
Mirochnick, Mark
Owen, Andrew
Siccardi, Marco
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (03) : 640 - 647
[44] PARAMETER OPTIMIZATION IN PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR THE PREDICTION OF TRANSPORTER-MEDIATED DRUG-DRUG INTERACTIONS WITH A NEW GLOBAL PARAMETER OPTIMIZATION METHOD
Yoshida, K.
Maeda, K.
Kusuhara, H.
Konagaya, A.
Sugiyama, Y.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S115 - S115
[45] Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study
Yoon, Miyoung
Kedderis, Gregory L.
Yan, Grace Zhixia
Clewell, Harvey J., III
TOXICOLOGY, 2015, 332 : 52 - 66
[46] Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection
Maruyama, Takumi
Kimura, Toshimi
Ebihara, Fumiya
Kasai, Hidefumi
Matsunaga, Nobuaki
Hamada, Yukihiro
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (12) : 1152 - 1159
[47] PREDICTION OF CEREBRAL MORPHINE CONCENTRATION IN PEDIATRIC TRAUMATIC BRAIN INJURY (TBI) WITH THE RAT PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODEL
Yamamoto, Y.
Ketharanathan, N.
de lange, E. C. M.
Rohlwink, U.
Wildschut, E. D.
Mathot, R. A. A.
Tibboel, D.
Figaji, A. A.
JOURNAL OF NEUROTRAUMA, 2016, 33 (03) : A38 - A38
[48] Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models
Nestorov, IA
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1999, 27 (06): : 577 - 596
[49] Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling:: theophylline and midazolam as model drugs
Björkman, S
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (06) : 691 - 704
[50] APPLICATION OF A PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODEL FOR PREDICTION OF THE DRUG-DRUG INTERACTION (DDI) BETWEEN LORAZEPAM AND PROBENECID
Neuhoff, Sibylle
Musther, Helen
Rowland-Yeo, Karen
DRUG METABOLISM REVIEWS, 2015, 47 : 121 - 121

← 1 2 3 4 5 →